These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 24292681)

  • 61. p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
    Davies C; Hogarth LA; Dietrich PA; Bachmann PS; Mackenzie KL; Hall AG; Lock RB
    J Biol Chem; 2011 Oct; 286(43):37639-50. PubMed ID: 21903579
    [TBL] [Abstract][Full Text] [Related]  

  • 62. p27(Kip1) and p21(Cip1)-independent proliferative inhibition of vascular smooth muscle cells cultured in type-I collagen matrix honeycombs.
    Uchida M; Suzuki S; Suzuki T; Ishii I
    Microvasc Res; 2016 Jan; 103():36-40. PubMed ID: 26522285
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells.
    Wiseman DA; Werner SR; Crowell PL
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1163-70. PubMed ID: 17138864
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Histone deacetylase inhibitors cause the TP53-dependent induction of p21/Waf1 in tumor cells carrying mutations in TP53].
    Kovalev RA; Shtam TA; Karelov DV; Burdakov VS; Volnitskiy AV; Makarov EM; Filatov MV
    Tsitologiia; 2015; 57(3):204-11. PubMed ID: 26021170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288).
    Meng LH; Kohn KW; Pommier Y
    Oncogene; 2007 Jul; 26(33):4806-16. PubMed ID: 17297446
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1.
    Gui CY; Ngo L; Xu WS; Richon VM; Marks PA
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1241-6. PubMed ID: 14734806
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response.
    Mensah AA; Kwee I; Gaudio E; Rinaldi A; Ponzoni M; Cascione L; Fossati G; Stathis A; Zucca E; Caprini G; Bertoni F
    Oncotarget; 2015 Mar; 6(7):5059-71. PubMed ID: 25671298
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
    Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.
    Kuwahara Y; Charboneau A; Knudsen ES; Weissman BE
    Cancer Res; 2010 Mar; 70(5):1854-65. PubMed ID: 20179200
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.
    Zuo X; Qin Y; Zhang X; Ning Q; Shao S; Luo M; Yuan N; Huang S; Zhao X
    Oncol Rep; 2014 May; 31(5):2358-64. PubMed ID: 24676336
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Obatoclax induces G1/G0-phase arrest via p38/p21(waf1/Cip1) signaling pathway in human esophageal cancer cells.
    Zhong D; Gu C; Shi L; Xun T; Li X; Liu S; Yu L
    J Cell Biochem; 2014 Sep; 115(9):1624-35. PubMed ID: 24788582
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 73. p21(Waf1) is required for cellular senescence but not for cell cycle arrest induced by the HDAC inhibitor sodium butyrate.
    Romanov VS; Abramova MV; Svetlikova SB; Bykova TV; Zubova SG; Aksenov ND; Fornace AJ; Pospelova TV; Pospelov VA
    Cell Cycle; 2010 Oct; 9(19):3945-55. PubMed ID: 20935470
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- mice.
    Yang W; Velcich A; Lozonschi I; Liang J; Nicholas C; Zhuang M; Bancroft L; Augenlicht LH
    Am J Pathol; 2005 Apr; 166(4):1239-46. PubMed ID: 15793302
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition.
    Noh EJ; Lee JS
    Biochem Biophys Res Commun; 2003 Oct; 310(2):267-73. PubMed ID: 14521905
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells.
    Yang L; Liang Q; Shen K; Ma L; An N; Deng W; Fei Z; Liu J
    Biomed Pharmacother; 2015 Apr; 71():70-8. PubMed ID: 25960218
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alterations in TP53, cyclin D2, c-Myc, p21WAF1/CIP1 and p27KIP1 expression associated with progression in B-CLL.
    Halina A; Artur P; Barbara MK; Joanna S; Anna D
    Folia Histochem Cytobiol; 2010 Dec; 48(4):534-41. PubMed ID: 21478095
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells.
    Laurenzana A; Balliu M; Cellai C; Romanelli MN; Paoletti F
    PLoS One; 2013; 8(3):e58267. PubMed ID: 23469273
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1).
    Okamoto H; Fujioka Y; Takahashi A; Takahashi T; Taniguchi T; Ishikawa Y; Yokoyama M
    J Atheroscler Thromb; 2006 Aug; 13(4):183-91. PubMed ID: 16908950
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cisplatin-DNA damage in p21WAF1/Cip1 deficient mouse keratinocytes exposed to cisplatin.
    van Gijssel HE; Leil TA; Weinberg WC; Divi RL; Olivero OA; Poirier MC
    Mutagenesis; 2007 Jan; 22(1):49-54. PubMed ID: 17158520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.